Evidence map›Paper›PMID 38487341›Full record

ArticleFrontiers in endocrinology2024

Identification and characterization of a novel CASR mutation causing familial hypocalciuric hypercalcemia.

Chien-Ming Lin, Yi-Xuan Ding, Shih-Ming Huang, Ying-Chuan Chen, Hwei-Jen Lee, Chih-Chien Sung, Shih-Hua Lin

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chien-Ming LinDepartment of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Yi-Xuan DingDepartment of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Shih-Ming HuangDepartment of Biochemistry, National Defense Medical Center, Taipei, Taiwan.
Ying-Chuan ChenDepartment of Physiology and Biophysics, National Defense Medical Center, Taipei, Taiwan.
Hwei-Jen LeeDepartment of Biochemistry, National Defense Medical Center, Taipei, Taiwan.
Chih-Chien SungDivision of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Shih-Hua LinDivision of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Tri-Service General Hospital · TWNational Defense Medical Center · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Although a monoallelic mutation in the calcium-sensing receptor ( Objective: A 45-year-old male presenting with moderate hypercalcemia, hypocalciuria, and inappropriately high parathyroid hormone (PTH) had a good response to cinacalcet (total serum calcium (Ca Design: Sanger sequencing of the Results: This proband was found to carry a Conclusion: This novel

Indexed as

HypercalcemiaHyperparathyroidismKidney DiseasesCalciumHumansMaleMiddle AgedMutationReceptors, Calcium-SensingCalciumCASR protein, humanReceptors, Calcium-Sensingcalcimimeticscalcium-sensing receptorfamilial hypocalciuric hypercalcemiahalf-maximal effective concentrationparathyroid hormone

Identifiers

PMID38487341
PMCPMC10937390
OpenAlexW4392292627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.